NYLIM
NUVB icon

New York Life Investment Management’s Nuvation Bio NUVB Stock Holding History

New York Life Investment Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-209,652
Closed -$317K – 1468
2023
Q4 		$317K Sell
209,652
-4,832
-2% -$6.22K ﹤0.01% 1186
2023
Q3 		$287K Sell
214,484
-33,790
-14% -$56.2K ﹤0.01% 1181
2023
Q2 		$447K Sell
248,274
-36,314
-13% -$61.7K ﹤0.01% 819
2023
Q1 		$472K Buy
+284,588
New +$577K 0.01% 1046

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

New York Life Investment Management's NUVB Position: Q1 2024 in Review

New York Life Investment Management sold out of Nuvation Bio (NUVB) in Q1 2024, closing a stake of 209,652 shares — an estimated $317K sold.

New York Life Investment Management first reported a position in NUVB in Q1 2023 and held it in 4 quarters. The position peaked at $472K in Q1 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q1 2024.

  • New York Life Investment Management reported no remaining Nuvation Bio position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 209,652 Nuvation Bio shares in Q1 2024, an estimated $317K.
  • New York Life Investment Management first reported a position in Nuvation Bio in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Nuvation Bio position peaked at $472K in Q1 2023.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.